TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less.....

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TATRADER who wrote (53725)	3/14/2006 10:00:10 AM
From: lexi2004	Read Replies (2) of 59879

To: lexi2004 who wrote (144915) 3/14/2006 7:23:47 AM From: Jo Ellen T Read Replies (1) of 144920 << ... Rodman & Renshaw raises their Novavax (NVAX 6.14) tgt to $10 from $6 as they believe Novavax V.L.P. technology to be the best novel flu vaccine technology, representing an emerging alternative to stockpiling traditional vaccines and antivirals against pandemic flu; they also believe NVAX to be an attractive acquisition candidate for any of the various vaccine manufacturers. >> Found this on yahoo but noone has a link yet. :) JE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next